Literature DB >> 23047546

A review of healthcare service and education provision of Autism Spectrum Condition in mainland China.

Xiang Sun1, Carrie Allison, Bonnie Auyeung, Simon Baron-Cohen, Carol Brayne.   

Abstract

Little is known about the current situation regarding Autism Spectrum Conditions in mainland China. Electronic databases and bibliographies were searched to identify literature on service provision for ASC in both English and Chinese databases. 14 studies and 6 reports were reviewed. The findings of identified papers on service provision were summarized according to four settings for ASC including healthcare, mainstream education, private special education, and state-run special education. The literature on the situation of the healthcare system and educational services for children with ASC in China was profoundly limited. There were great financial problems faced by the parents of autistic children which were partly due to the under-developed healthcare and educational system for ASC.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23047546     DOI: 10.1016/j.ridd.2012.08.013

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  12 in total

1.  Predictors of Mental Health in Chinese Parents of Children with Autism Spectrum Disorder (ASD).

Authors:  Xueyun Su; Ru Ying Cai; Mirko Uljarević
Journal:  J Autism Dev Disord       Date:  2018-04

2.  Sleep Disturbances and Associated Factors in Chinese Children with Autism Spectrum Disorder: A Retrospective and Cross-Sectional Study.

Authors:  Guanghai Wang; Zhijun Liu; Guangxing Xu; Fan Jiang; Ning Lu; Allison Baylor; Judith Owens
Journal:  Child Psychiatry Hum Dev       Date:  2016-04

3.  Validation of existing diagnosis of autism in mainland China using standardised diagnostic instruments.

Authors:  Xiang Sun; Carrie Allison; Bonnie Auyeung; Zhixiang Zhang; Fiona E Matthews; Simon Baron-Cohen; Carol Brayne
Journal:  Autism       Date:  2015-03-10

4.  Service provision for autism in mainland China: preliminary mapping of service pathways.

Authors:  Xiang Sun; Carrie Allison; Bonnie Auyeung; Fiona E Matthews; Simon Baron-Cohen; Carol Brayne
Journal:  Soc Sci Med       Date:  2013-08-27       Impact factor: 4.634

5.  Statistical analysis of twenty years (1993 to 2012) of data from mainland China's first intervention center for children with autism spectrum disorder.

Authors:  Wei-Zhen Zhou; Adam Yongxin Ye; Zhong-Kai Sun; Hope Huiping Tian; Tad Zhengzhang Pu; Yu-Yu Wu; Dan-Dan Wang; Ming-Zhen Zhao; Shu-Juan Lu; Chang-Hong Yang; Liping Wei
Journal:  Mol Autism       Date:  2014-11-12       Impact factor: 7.509

6.  Autism prevalence in China is comparable to Western prevalence.

Authors:  Simon Baron-Cohen; Carol Brayne; Xiang Sun; Carrie Allison; Liping Wei; Fiona E Matthews; Bonnie Auyeung; Yu Yu Wu; Sian Griffiths; Jie Zhang
Journal:  Mol Autism       Date:  2019-02-28       Impact factor: 7.509

7.  Comparison of Services for Autism Spectrum Disorder in Massachusetts with Those in Seoul.

Authors:  Jung Won Kim; Hyo Won Kim; Duk Soo Moon; Yun Shin Lim; Christopher J McDougle; Yamini Jagannath Howe
Journal:  J Korean Med Sci       Date:  2019-11-11       Impact factor: 2.153

8.  Psychometric properties of the Mandarin version of the Childhood Autism Spectrum Test (CAST): an exploratory study.

Authors:  Xiang Sun; Carrie Allison; Bonnie Auyeung; Fiona E Matthews; Samuel Norton; Simon Baron-Cohen; Carol Brayne
Journal:  J Autism Dev Disord       Date:  2014-07

9.  Prevalence of autism in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis.

Authors:  Xiang Sun; Carrie Allison; Fiona E Matthews; Stephen J Sharp; Bonnie Auyeung; Simon Baron-Cohen; Carol Brayne
Journal:  Mol Autism       Date:  2013-04-09       Impact factor: 7.509

10.  Brief Report: Health Expenditures for Children with Autism and Family Financial Well-Being in China.

Authors:  Ling Zhou; Jiebiao Wang; Jin Huang
Journal:  J Autism Dev Disord       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.